CBD Myths, Busted: Cutting Through the Noise With What 2024 Research Actually Confirms

Let's be honest: the CBD industry has a credibility problem. Not because the science isn't there — it increasingly is — but because years of overclaiming, under-regulating, and outright misinformation have made it genuinely hard for everyday consumers to know what to believe. Walk into any grocery store and you'll find CBD in everything from dog treats to sparkling water. The marketing is everywhere. The clarity, less so.

At Denver Farms CBD, we'd rather have a straight conversation than sell you a fantasy. So we've pulled together the most persistent myths floating around the CBD space and matched them against the best available evidence heading into 2024. No hype. No fear-mongering. Just what we actually know.

Myth #1: CBD Will Get You High

The reality: No, it won't — and this is probably the single most important misconception to clear up.

CBD (cannabidiol) and THC (tetrahydrocannabinol) are both cannabinoids found in the cannabis plant, but they behave very differently in the body. THC binds directly to CB1 receptors in the brain, producing the psychoactive "high" associated with marijuana. CBD doesn't bind to those receptors in the same way — in fact, some research suggests it may actually reduce THC's psychoactive effects when both compounds are present.

Hemp-derived CBD products, including the gummies sold here at Denver Farms, are required by federal law to contain no more than 0.3% THC by dry weight. That's a trace amount — not enough to produce any psychoactive effect. You will not feel impaired, altered, or "stoned" from a properly formulated hemp-derived CBD gummy.

If someone told you CBD gets you high, they were either confused about the science or conflating hemp-derived CBD with marijuana products. They're not the same thing.

Myth #2: CBD Is Legal Everywhere in the US

The reality: Mostly, but not entirely — and the details matter.

The 2018 Farm Bill was a landmark piece of legislation that federally legalized hemp and hemp-derived products containing less than 0.3% THC. That was a big deal. For most Americans in most states, purchasing and consuming hemp-derived CBD gummies is completely legal.

However, a handful of states have imposed their own restrictions. As of 2024, states including Idaho have maintained stricter rules around hemp-derived cannabinoids, and regulations around CBD in food and beverages vary by state. The FDA has also been slow to establish a comprehensive regulatory framework for CBD as a dietary supplement, which creates some gray areas.

The practical takeaway for most US consumers: if you're buying a hemp-derived CBD product from a reputable company with transparent lab testing, you're almost certainly in the clear. But if you're traveling or moving between states, it's worth doing a quick check on local laws. The patchwork nature of US cannabis regulation is frustrating, but it's the reality we're operating in.

Myth #3: CBD Will Show Up on a Drug Test

The reality: Pure CBD won't — but some products carry more risk than others.

This is where things get genuinely important for anyone subject to workplace drug testing. Standard drug tests screen for THC metabolites, not CBD. So if you're consuming a pure CBD isolate product with no detectable THC, your risk of testing positive is extremely low.

The complication arises with full-spectrum CBD products, which contain the full range of naturally occurring cannabinoids in hemp — including trace amounts of THC. In theory, those trace amounts shouldn't be enough to trigger a positive test. In practice, some studies have shown that heavy use of full-spectrum products can occasionally result in detectable THC levels, particularly for people who metabolize cannabinoids slowly.

If drug testing is a concern for you, broad-spectrum or CBD isolate products — which contain either zero or near-zero THC — are the safer choice. Always check the certificate of analysis (COA) for any product you're considering. A trustworthy company will make those lab results easy to find.

Myth #4: All CBD Products Are Basically the Same

The reality: The variation in quality across the industry is enormous.

This one frustrates us, because it undersells how much sourcing, processing, and formulation actually matter. Two gummies with identical CBD milligram counts can deliver very different experiences depending on:

• Hemp source and growing conditions: Hemp grown in nutrient-rich, well-managed soil at altitude (hello, Colorado) tends to produce a richer cannabinoid and terpene profile than hemp grown in depleted industrial conditions.
• Extraction method: CO2 extraction is widely considered the gold standard — it preserves beneficial compounds without introducing chemical solvents.
• Third-party testing: Without independent lab verification, you're taking a company's word for what's actually in the product. COAs from accredited labs are non-negotiable for any brand worth trusting.
• Formulation: Gummies made with quality ingredients and proper bioavailability considerations will outperform cheaply made alternatives, even at the same CBD concentration.

The 2024 landscape includes some genuinely excellent CBD products — and a lot of mediocre ones. Price isn't always a reliable guide. Lab transparency is.

Myth #5: CBD Is Just a Placebo

The reality: The clinical evidence is growing, and it's not trivial.

Skeptics sometimes dismiss CBD as an expensive wellness trend propped up by wishful thinking. The research tells a more complicated story. The FDA's 2018 approval of Epidiolex — a pharmaceutical-grade CBD medication for treatment-resistant epilepsy — established beyond reasonable doubt that CBD has real, measurable neurological effects.

Beyond epilepsy, 2024 research continues to build the evidence base for CBD's potential in areas including:

• Anxiety reduction: Multiple studies have found meaningful reductions in anxiety scores among participants using CBD, with a 2023 meta-analysis in Neurotherapeutics supporting its anxiolytic properties.
• Sleep quality: Research consistently links CBD's effect on cortisol and the endocannabinoid system to improved sleep onset and continuity.
• Inflammation: Preclinical research on CBD's interaction with inflammatory pathways remains one of the most active areas of study.

None of this means CBD is a cure-all. It isn't. The research also shows that CBD doesn't work the same way for everyone, and dosing remains an imprecise science. But "it's all in your head" doesn't hold up against the existing body of peer-reviewed literature.

Myth #6: More CBD Always Means Better Results

The reality: CBD follows what researchers call a biphasic dose-response curve — meaning more isn't always more.

This surprises a lot of people. Studies suggest that CBD can have different effects at different doses. Lower doses often produce stimulating, alertness-promoting effects, while higher doses tend toward sedation and relaxation. For sleep, a higher dose before bed might make sense. For daytime anxiety management, a lower dose may actually be more effective.

The practical implication: start with a modest dose, give it time (at least a week or two of consistent use), and adjust gradually. Doubling your gummies on day one because you "didn't feel anything" is a common mistake — and an expensive one.

Why Transparency Matters More Than Marketing

The myths above persist for a reason: the CBD industry, for much of its early history, was more interested in selling products than educating consumers. Regulatory gaps allowed companies to make sweeping health claims without evidence, flood the market with untested products, and generally prioritize hype over honesty.

We think that era is winding down — partly because consumers are smarter and more demanding, and partly because the regulatory environment is tightening. The brands that will earn long-term trust are the ones willing to say "here's what we know, here's what we don't know, and here's the lab report to back it up."

That's the standard we hold ourselves to at Denver Farms CBD. Rocky Mountain roots, real science, no shortcuts.

If you've got questions we didn't answer here, reach out. We'd rather have the honest conversation.